Rockwell Medical (RMTI) Tops Q3 EPS by 8c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $8.08 -0.12%
Financial Fact:
Interest and Dividend Income: 188.85K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Interest and Dividend Income: 188.85K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q3 EPS of $0.09, $0.08 better than the analyst estimate of $0.01. Revenue for the quarter came in at $28.3 million versus the consensus estimate of $26.5 million.
GUIDANCE:
Rockwell Medical sees FY2024 revenue of $98-101 million, versus the consensus of $100.2 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Flutter Entertainment plc (FLUT) Misses Q3 EPS by 525c; lowers guidance
- XPEL, Inc. (XPEL) Tops Q3 EPS by 4c, Misses on Revenue; Offers Q4 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
